More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

VolitionRx (VNRX) announced the results of a large-scale study which shows that its Nu.Q NETs H3.1 biomarker is an independent predictor of ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the results of a large-scale study which shows that its Nu.Q®NETs H3.1 biomarker is an ...

Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk ...

The Philippine Health Insurance Corporation (PhilHealth) has expanded the Z Benefit package for Peritoneal Dialysis (PD) with ...

The Philippine Health Insurance Corporation (PhilHealth) has substantially enhanced its Z Benefit Package for Peritoneal ...

Pediatric patients can receive P510,000 to P765,210 for CAPD and P763,000 to P1.2 million for APD. The package also includes coverage for related services like infection prevention and treatment for ...

Rodman & Renshaw initiated coverage on shares of biopharmaceutical company Talphera (NASDAQ: TLPH) with a Buy rating and a price target of $4.00. The firm's analysts highlighted Talphera's focus on ...

We are delighted that QUELIMMUNE is now available to treat severely ill children at yet another prominent academic medical center,” said Tim Varacek, SeaStar Medical Senior Vice President, Commercial ...

The trial is assessing the efficacy and safety of the company's selective cytopheretic device (SCD) in conjunction with continuous renal replacement therapy (CRRT). The trial aims to enrol 200 adult ...

Do note that, Ruffle is developed with the Rust programming language. Shubus Viewer is a great replacement for Adobe Flash Player in 2021 for anyone who used flash player to play online games. Using ...